CG
HRMY icon

Cutler Group’s Harmony Biosciences HRMY Stock Holding History

Cutler Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$10K Sell
300
-400
-57% -$12.8K ﹤0.01% 1276
2023
Q4 		$22K Sell
700
-1,703
-71% -$47.5K ﹤0.01% 1913
2023
Q3 		$78K Buy
+2,403
New +$83.4K 0.01% 1257

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cutler Group's HRMY Position: Q1 2024 in Review

Cutler Group reduced its Harmony Biosciences (HRMY) stake by 57% in Q1 2024, selling an estimated $12.8K and leaving 300 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1276.

Cutler Group first reported a position in HRMY in Q3 2023 and has held it in 3 quarters since. The position peaked at $78K in Q3 2023. 208 funds tracked by Wall St. Rank hold HRMY as of Q1 2024.

  • Cutler Group held 300 shares of Harmony Biosciences worth $10K as of Q1 2024.
  • Cutler Group sold 400 Harmony Biosciences shares in Q1 2024, an estimated $12.8K.
  • Harmony Biosciences made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1276 holding.
  • Cutler Group first reported a position in Harmony Biosciences in Q3 2023 and has held it in 3 quarters since.
  • Cutler Group's Harmony Biosciences position peaked at $78K in Q3 2023.
  • 208 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.